PhageTech Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $500K
Latest Deal Amount
  • Investors
  • 8

PhageTech General Information

Description

Developer of bio-medical sensors designed for detecting analytes in body fluid. The company's sensors use bacteriophages bond to detect analytes in urine, blood, and most any other body fluid along with cancer and infectious diseases in their earliest stages accurately, enabling physicians to treat patients conveniently and instantaneously.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • 5 Mason
  • Suite 170
  • Irvine, CA 92618
  • United States
+1 (949) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PhageTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 23-May-2017 $500K 00.00 Completed Startup
3. Early Stage VC (Series A) 01-Oct-2015 00.00 00.00 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Grant $2.2M Completed Startup
To view PhageTech’s complete valuation and funding history, request access »

PhageTech Executive Team (7)

Name Title Board Seat Contact Info
Richard Henson Co-Founder, Co-Chief Executive Officer & Board Member
Rodney Brenneman Co-Chief Executive Officer
Margaret Cate Chief Financial Officer
Howard Robin MD Chief Technology Officer
Gregory Weiss Ph.D Co-Founder, Chief Scientific Officer & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

PhageTech Board Members (8)

Name Representing Role Since
Gregory Weiss Ph.D PhageTech Co-Founder, Chief Scientific Officer & Board Member 000 0000
Jack Syage Ph.D Self Board Member 000 0000
Jack Van Berkel Self Board Member 000 0000
Jeff Manassero Self Board Member 000 0000
Paul Cate Mark IV Capital Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

PhageTech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PhageTech Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Black River Asset Management Hedge Fund Minority 000 0000 000000 0
Jeff Manassero Angel (individual) Minority 000 0000 000000 0
Mark IV Capital Real Estate Minority 000 0000 000000 0
The VineOC Accelerator/Incubator Minority 000 0000 000000 0
Cove Fund Growth/Expansion Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »